Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France

François-Emery Cotté, Gérard De Pouvourville

Open source

DOI
10.1186/1472-6963-11-151
Published
2011-06-25
Container
BMC Health Services Research
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/1472-6963-11-151,
  title = {Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France},
  author = {François-Emery Cotté and Gérard De Pouvourville},
  year = {2011},
  journal = {BMC Health Services Research},
  doi = {10.1186/1472-6963-11-151},
  url = {https://doi.org/10.1186/1472-6963-11-151}
}

RIS

TY  - JOUR
TI  - Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
AU  - François-Emery Cotté
AU  - Gérard De Pouvourville
PY  - 2011
JO  - BMC Health Services Research
DO  - 10.1186/1472-6963-11-151
UR  - https://doi.org/10.1186/1472-6963-11-151
ER  - 

APA

Cotté, F., & Pouvourville, G. D. (2011). Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France. BMC Health Services Research. https://doi.org/10.1186/1472-6963-11-151

Source records